Congruence Medical Solutions is a company dedicated to addressing compelling needs in injectable drug delivery. Founded in 2015, the company's purpose is to enhance the clinical and commercial impact of injectable drugs with unsolved, emerging, and hard-to-address delivery needs. Congruence designs, develops, and supplies innovative drug delivery device platforms that incorporate standard primary containers, such as third-party pre-fillable syringes. The company's portfolio has been developed in partnership with multiple pharma and biotech customers who trust its domain expertise and value its passion, innovation, responsiveness, and integrity. As subject-matter experts in ophthalmic drug delivery, Congruence invented the award-winning Microliter Dosing Syringe, establishing itself as the leader in small-volume drug delivery. The company has expanded its portfolio to address compelling delivery needs in various areas, including viscous drug delivery, multi-dosing, variable dosing, and minimizing drug waste. Congruence's innovation and customer-centric approach position it as a promising candidate for investment in the healthcare and pharmaceutical industries.
There is no investment information
No recent news or press coverage available for Congruence Medical Solutions.